Research and experimental development on natural sciences and engineering
KEIMON MEDICAL AS
Revenue 2025
NOK 500,000
Operating profit
NOK −1.8m
Equity
NOK −1.3m
Incorporated
2022
Share capital
NOK 100,000
Key figures · 2025
Current ratio
0.19
Equity ratio
-423.1%
Key figures over time · 2025
| Key figures | 2025 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | -358.6% | |
| Net margin (%%) | -368.6% | |
| Return on assets (%%) | -599.8% | |
| Likviditet | ||
| Current ratio | 0.19 | |
| Working capital | −1.3m | |
| Soliditet | ||
| Equity ratio (%%) | -423.1% | |
| Debt-to-equity ratio | -1.24 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.